Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Print1
- Journal1
- Article Type
- Clinical Trial1
- Randomized Controlled Trial1
- Clinical Study1
- Comparative Study1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Med Klin1
Search Results
Sort by
- Book[edited by] Patricia A. Potter, Anne Griffin Perry, Patricia A. Stockert, Amy M. Hall.Summary: Textbook for Nursing Fundamentals, Complex Health Alterations, ADN Psych Clinical, Nursing Advanced Skills, and LPN/RN Refresher Skills.
- ArticleAdjan M.Med Klin. 1978 Jun 30;73(26):987-9.In a placebo-controlled double blind study 20 patients suffering from angina pectoris were treated with Stenoptin. The patients had 5 attacks at least per week and consumed 5 chwable nitrocapsules and more. Criteria of success were consumption of chewable nitrocapsules and frequency of attacks. During a 7 day preobservation period the patients received a placebo identical with Stenoptin and 20 chewable nitrocapsules. The study lasted for 8 weeks. The dose was 1 tablet 3 times per day. The attacks of the active substance group were reduced from 11 to 2 on the average, and the nitro-consumption from 16 to 2 per week. In the placebo group frequency of attack slightly increased from 10 to 11. In the active substance group the dose could be reduced to 1 tablet twice per day. The placebo group was treated with 1 Stenoptin tablet 3 times per day for another 8 weeks. Subsequently 1 tablet twice per day sufficed. Transient, nitro-induced headache occurred only in 3 test persons. Stenoptin did not cause side effects and was very effective in serious types of angina pectoris.